Sponsor link https://cdmrp.army.mil/funding/arp

Clinical Trial Award – Preproposal due May 23, 2022

Investigators at or above the level of Assistant Professor (or equivalent) or

Early-Career Investigator Partnering Principal Investigator (PI) Option:  Investigators at or above the level of Assistant Professor (or equivalent) may collaborate on a single application with a young investigator (at the level of postdoctoral fellow up to early-career independent faculty) who meets the following criteria as of the application submission deadline date:

• Must be in a current postdoctoral training position or have completed postdoctoral training by the application deadline
• Is no more than 7 years from the receipt of a terminal degree
• Has the freedom to commit at least 50% time to the project

• Supports research with the potential to have a major impact on the treatment and/or management of autism spectrum disorders (ASD).
• Preliminary data relevant to the proposed project are required.

• Early-Career Investigator Partnering PI Option supports the development of young investigators pursuing or wishing to pursue a career in ASD clinical trial research.

Pre-application is required; application submission is by invitation only.

• The maximum period of performance is 4 years.
• The maximum allowable funding for the entire period of performance is $1,800,000 in direct costs (plus indirect costs).
• Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.

Early-Career Investigator Partnering PI Option:

• The maximum period of performance is 4 years.
• The maximum allowable funding for the entire period of performance is $2,100,000 for direct costs (plus indirect costs).
• Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.

Idea Development Award – Preproposal due May 23, 2022

Investigators at or above the level of Assistant Professor (or equivalent)

Multiple PI Option: 
Up to two investigators may collaborate on a single application, each of whom will be recognized as a Principal Investigator and receive a separate award. 

• Supports the development of innovative, high-impact ideas that advance the understanding of ASD and ultimately lead to improved outcomes.
• Preliminary data relevant to the proposed project are required.
• Multiple PI Option: Up to two inestigators may collaborate ona single application, each of whom will be recognized as a PI and receive a separate award.
• Clinical trials or applications, including a clinical trial aim, are not allowed.
• Pre-application is required; application submission is by invitation only.
• The maximum period of performance is 3 years.
• The maximum allowable funding for the entire period of performance is $550,000 in direct costs (plus indirect costs).
• For multiple PIs, the combined funding for all PIs for the entire period of performance may not exceed $550,000 in direct costs (plus indirect costs).
• Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.

Career Development Award – Preproposal due May 23, 2022

Independent investigators at or below the level of Assistant Professor (or equivalent) or

Established independent investigators in an area other than ASD at or above the level of Assistant Professor (or equivalent) and seeking to transition to a career in ASD, thereby bringing their expertise to the field

Investigators must not have received a Career Development Award (or equivalent) previously from any program within the Congressionally Directed Medical Research Programs.

Investigators must not have received more than $300,000 in total direct costs for previous or concurrent ASD research as a PI of one or more federally or privately funded non-mentored, peer-reviewed grants.

Investigators must hold a Ph.D, M.D., M.D./Ph.D, or equivalent at time of pre-application submission

• Supports early-career, independent investigators and/or the transition of established investigators from other research fields to conduct:

• Innovative, high-impact ideas or
• Early-phase, proof-of-principle clinical trials with the potential to have a major impact on ASD

• Preliminary data relevant to the proposed project are required.

Pre-application is required; application submission is by invitation only.

• The maximum period of performance is 3 years.
• The maximum allowable funding for the entire period of performance is $550,000 in direct costs (plus indirect costs).
• Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.